-
Start Preamble
By Notice dated June 17, 2010 and published in the Federal Register on June 28, 2010, (75 FR 36681), Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Methcathinone (1237) I N-Ethylamphetamine (1475) I N,N-Dimethylamphetamine (1480) I 4-Methylaminorex (cis isomer) (1590) I Alpha-ethyltryptamine (7249) I Lysergic acid diethylamide (7315) I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) I Tetrahydrocannabinols (7370) I Mescaline (7381) I 4-Bromo-2,5-dimethoxyamphetamine (7391) I 4-Bromo-2,5-dimethoxyphenethylamine (7392) I 4-Methyl-2,5-dimethoxyamphetamine (7395) I 2,5-Dimethoxyamphetamine (7396) I 2,5-Dimethoxy-4-ethylamphetamine (7399) I 3,4-Methylenedioxyamphetamine (7400) I N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxymethamphetamine (MDMA) (7405) I 4-Methoxyamphetamine (7411) I Alpha-methyltryptamine (7432) I Bufotenine (7433) I Diethyltryptamine (7434) I Dimethyltryptamine (7435) I Psilocybin (7437) I Psilocyn (7438) I 5-Methoxy-N,N-diisopropyltryptamine (7439) I N-Ethyl-1-phenylcyclohexylamine (7455) I 1-(1-Phenylcyclohexyl)pyrrolidine (7458) I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I Dihydromorphine (9145) I Normorphine (9313) I Methamphetamine (1105) II 1-Phenylcyclohexylamine (7460) II Phencyclidine (7471) II Phenylacetone (8501) II 1-Piperidinocyclohexanecarbonitrile (8603) II Cocaine (9041) II Codeine (9050) II Dihydrocodeine (9120) II Ecgonine (9180) II Meperidine intermediate-B (9233) II Noroxymorphone (9668) II The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Alltech Associates Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted Start Printed Page 69464registration as a bulk manufacturer of the basic classes of controlled substances listed.
Start SignatureDated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2010-28536 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 11/12/2010
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 2010-28536
- Pages:
- 69463-69464 (2 pages)
- PDF File:
- 2010-28536.pdf